线

Raphael Lutz1,2,3,4, Florian Grünschläger3,4,5, Malte Simon5,6,7

  • 1Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.

Nature communications
|November 29, 2024
PubMed
概括

多发性骨髓瘤幸存者在骨髓中表现出持久的免疫系统变化,即使在治疗后数年. 这些与残留癌症或治疗相关的变化表明永久的"免疫性痕".